CovidV2, Ncbi, Merge, bibRecord, 000E38

Remdesivir as a possible therapeutic option for the COVID-19.

Identifieur interne : 000E38 ( Ncbi/Merge ); précédent : 000E37; suivant : 000E39

Remdesivir as a possible therapeutic option for the COVID-19.

Auteurs : Jaffar A. Al-Tawfiq [États-Unis] ; Ali H. Al-Homoud [Arabie saoudite] ; Ziad A. Memish [États-Unis]

Source :

Travel medicine and infectious disease [ 1873-0442 ] ; 2020.

RBID : pubmed:32145386
DOI: 10.1016/j.tmaid.2020.101615
PubMed: 32145386

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000743
to stream PubMed, to step Curation: 000743
to stream PubMed, to step Checkpoint: 000371

Links to Exploration step

pubmed:32145386

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Remdesivir as a possible therapeutic option for the COVID-19.</title>
<author><name sortKey="Al Tawfiq, Jaffar A" sort="Al Tawfiq, Jaffar A" uniqKey="Al Tawfiq J" first="Jaffar A" last="Al-Tawfiq">Jaffar A. Al-Tawfiq</name>
<affiliation wicri:level="2"><nlm:affiliation>Infectious Disease Unit, Specialty Internal Medicine and Infection Control Unit, Quality and Patient Safety, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jaffar.tawfiq@jhah.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Infectious Disease Unit, Specialty Internal Medicine and Infection Control Unit, Quality and Patient Safety, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Al Homoud, Ali H" sort="Al Homoud, Ali H" uniqKey="Al Homoud A" first="Ali H" last="Al-Homoud">Ali H. Al-Homoud</name>
<affiliation wicri:level="1"><nlm:affiliation>Pharmacy Services Division, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Pharmacy Services Division, Johns Hopkins Aramco Healthcare, Dhahran</wicri:regionArea>
<wicri:noRegion>Dhahran</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Memish, Ziad A" sort="Memish, Ziad A" uniqKey="Memish Z" first="Ziad A" last="Memish">Ziad A. Memish</name>
<affiliation wicri:level="2"><nlm:affiliation>Director Research Center, King Saud Medical City, Ministry of Health, Saudi Arabia; Al-Faisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Director Research Center, King Saud Medical City, Ministry of Health, Saudi Arabia; Al-Faisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32145386</idno>
<idno type="pmid">32145386</idno>
<idno type="doi">10.1016/j.tmaid.2020.101615</idno>
<idno type="wicri:Area/PubMed/Corpus">000743</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000743</idno>
<idno type="wicri:Area/PubMed/Curation">000743</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000743</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000371</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000371</idno>
<idno type="wicri:Area/Ncbi/Merge">000E38</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Remdesivir as a possible therapeutic option for the COVID-19.</title>
<author><name sortKey="Al Tawfiq, Jaffar A" sort="Al Tawfiq, Jaffar A" uniqKey="Al Tawfiq J" first="Jaffar A" last="Al-Tawfiq">Jaffar A. Al-Tawfiq</name>
<affiliation wicri:level="2"><nlm:affiliation>Infectious Disease Unit, Specialty Internal Medicine and Infection Control Unit, Quality and Patient Safety, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jaffar.tawfiq@jhah.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Infectious Disease Unit, Specialty Internal Medicine and Infection Control Unit, Quality and Patient Safety, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Al Homoud, Ali H" sort="Al Homoud, Ali H" uniqKey="Al Homoud A" first="Ali H" last="Al-Homoud">Ali H. Al-Homoud</name>
<affiliation wicri:level="1"><nlm:affiliation>Pharmacy Services Division, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Pharmacy Services Division, Johns Hopkins Aramco Healthcare, Dhahran</wicri:regionArea>
<wicri:noRegion>Dhahran</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Memish, Ziad A" sort="Memish, Ziad A" uniqKey="Memish Z" first="Ziad A" last="Memish">Ziad A. Memish</name>
<affiliation wicri:level="2"><nlm:affiliation>Director Research Center, King Saud Medical City, Ministry of Health, Saudi Arabia; Al-Faisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Director Research Center, King Saud Medical City, Ministry of Health, Saudi Arabia; Al-Faisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Travel medicine and infectious disease</title>
<idno type="eISSN">1873-0442</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32145386</PMID>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-0442</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Mar</Month>
<Day>05</Day>
</PubDate>
</JournalIssue>
<Title>Travel medicine and infectious disease</Title>
<ISOAbbreviation>Travel Med Infect Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Remdesivir as a possible therapeutic option for the COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>101615</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1477-8939(20)30083-1</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tmaid.2020.101615</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Tawfiq</LastName>
<ForeName>Jaffar A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo><Affiliation>Infectious Disease Unit, Specialty Internal Medicine and Infection Control Unit, Quality and Patient Safety, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jaffar.tawfiq@jhah.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Al-Homoud</LastName>
<ForeName>Ali H</ForeName>
<Initials>AH</Initials>
<AffiliationInfo><Affiliation>Pharmacy Services Division, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Memish</LastName>
<ForeName>Ziad A</ForeName>
<Initials>ZA</Initials>
<AffiliationInfo><Affiliation>Director Research Center, King Saud Medical City, Ministry of Health, Saudi Arabia; Al-Faisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>03</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Travel Med Infect Dis</MedlineTA>
<NlmUniqueID>101230758</NlmUniqueID>
<ISSNLinking>1477-8939</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CoiStatement>Declaration of competing interest All authors have no conflicts of interest.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>02</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>02</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>03</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32145386</ArticleId>
<ArticleId IdType="pii">S1477-8939(20)30083-1</ArticleId>
<ArticleId IdType="doi">10.1016/j.tmaid.2020.101615</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Arabie saoudite</li>
<li>États-Unis</li>
</country>
<region><li>Géorgie (États-Unis)</li>
<li>Maryland</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Al Tawfiq, Jaffar A" sort="Al Tawfiq, Jaffar A" uniqKey="Al Tawfiq J" first="Jaffar A" last="Al-Tawfiq">Jaffar A. Al-Tawfiq</name>
</region>
<name sortKey="Memish, Ziad A" sort="Memish, Ziad A" uniqKey="Memish Z" first="Ziad A" last="Memish">Ziad A. Memish</name>
</country>
<country name="Arabie saoudite"><noRegion><name sortKey="Al Homoud, Ali H" sort="Al Homoud, Ali H" uniqKey="Al Homoud A" first="Ali H" last="Al-Homoud">Ali H. Al-Homoud</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E38 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000E38 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:32145386
   |texte=   Remdesivir as a possible therapeutic option for the COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:32145386" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV2

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021

	Serveur d'exploration Covid (26 mars)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Covid (26 mars)

Remdesivir as a possible therapeutic option for the COVID-19.

Remdesivir as a possible therapeutic option for the COVID-19.

Source :

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki